Bank of Montreal’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,800
Closed -$9.92M 3570
2025
Q1
$9.92M Buy
+22,800
New +$9.15M ﹤0.01% 932
2019
Q2
Sell
-31,300
Closed -$8.98M 4903
2019
Q1
$8.98M Buy
31,300
+27,300
+683% +$7.9M 0.01% 888
2018
Q4
$1.05M Buy
+4,000
New +$1.1M ﹤0.01% 1865

Other funds holding ELV

Bank of Montreal's ELV Position: Q2 2026 in Review

Bank of Montreal increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $10.5M and bringing the position to 252,092 shares worth $97.5M. The position accounts for 0.03% of the portfolio, ranked #398.

Bank of Montreal first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $240M in Q1 2024. 1,117 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bank of Montreal held 252,092 shares of Elevance Health worth $97.5M as of Q2 2026.
  • Bank of Montreal bought 28,373 Elevance Health shares in Q2 2026, an estimated $10.5M.
  • Elevance Health made up 0.03% of Bank of Montreal's portfolio in Q2 2026, its #398 holding.
  • Bank of Montreal first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Elevance Health position peaked at $240M in Q1 2024.
  • 1,117 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.